AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,813 | -15.1% | 21,945 | 0.0% | 0.03% | -11.1% |
| Q2 2023 | $473,354 | -26.5% | 21,945 | 0.0% | 0.04% | -30.8% |
| Q1 2023 | $643,867 | -35.8% | 21,945 | -19.2% | 0.05% | -38.1% |
| Q4 2022 | $1,003,008 | +111.2% | 27,145 | +61.0% | 0.08% | +95.3% |
| Q3 2022 | $475,000 | – | 16,865 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,472,033 | $154,038,000 | 4.47% |
| Ghost Tree Capital, LLC | 550,000 | $15,483,000 | 4.35% |
| Ghost Tree Capital, LLC | 500,000 | $14,075,000 | 3.95% |
| Bain Capital Life Sciences Investors, LLC | 1,023,214 | $28,803,000 | 3.44% |
| Boxer Capital, LLC | 2,084,000 | $58,665,000 | 3.30% |
| Alpha Wave Global, LP | 700,635 | $19,723,000 | 2.33% |
| Soleus Capital Management, L.P. | 429,336 | $12,086,000 | 1.64% |
| Ikarian Capital, LLC | 250,000 | $7,037,000 | 1.40% |
| Cormorant Asset Management, LP | 610,000 | $17,172,000 | 1.20% |
| SECTORAL ASSET MANAGEMENT INC | 205,400 | $5,782,000 | 1.14% |